BUY Cohance Lifesciences Limited — Amit Shreeram Goel
byAmit Shreeram GoelHorizon: NA (inferred Swing (≤2wk))21 Aug 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·20 Aug · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cohance Lifesciences
- BUY — Arun Kumar Mantri21 Oct 2026 · ~2 weeks · target ₹495 · SL hit
- BUY — Investec India21 Oct 2026 · ~1 year · target ₹560 · Active
- BUY — IDBI Capital7 Oct 2026 · ~2 weeks · target ₹490 · SL hit
- BUY — Mehul Kothari, Anand Rathi20 Aug 2026 · ~3 months · target ₹550 · SL hit
- BUY — Kunal Saraogi18 Aug 2026 · ~3 months · target ₹530 · Active
More from Amit Shreeram Goel
- BUY Reliance Industries16 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY Apollo Hospitals Enterprise9 Oct 2026 · ~2 weeks · target ₹8,800 · SL hit
- BUY Laurus Labs9 Oct 2026 · ~2 weeks · target ₹2,172 · SL hit
- SELL Union Bank of India30 Sept 2026 · ~2 weeks · target ₹166 · Expired
- BUY Prestige Estates Projects30 Sept 2026 · ~2 weeks · target ₹1,531 · Expired

